Daniel Primavessy, PhD, studied Bioinformatics and Biotechnology at Saarland University (Saarbrücken, Germany) from 2003 to 2011 and completed his PhD from 2011 to 2017 at Philipps-University (Marburg,
Germany) on peptide encapsulation into polymeric nanoparticulate and microparticulate systems.
He worked for two years as a post doctoral researcher at Saarland University and two years in a contract research organisation focusing on pulmonary in vitro instruments. In 2021, he joined Midas Pharma. As Project Manager and Scientist, Dr Primavessy’s work focuses on the evaluation of pharmaceutical innovation projects in device and formulation technology and the development of pharmaceutical products.